Sophie Hughes is an Investment Analyst at Seroba. She has a background in pharmaceutical research and development, working for GlaxoSmithKline and Cancer Research UK Therapeutic Discovery Laboratories. Prior to joining Seroba in 2023 she completed her DPhil (PhD) in Oncology from the University of Oxford, investigating the interplay between the immune microenvironment and pancreatic cancer. In tandem to the completion of her DPhil, she developed market entry strategies for biotech ventures through the Creative Destruction Lab at the Saïd Business School. In addition to her professional roles, Sophie serves on the board of YVC Collective, a network of emerging life sciences venture capital professionals.
-
Name:Sophie Hughes
-
Job Title:Analyst, Seroba Life Sciences